In two of tested cancer cell lines (ZL55 and MCF-7) we observed a significant decrease of cell proliferation after treatment with lovastatin, indicating that even p53-proficient tumors may be sensitive to some extent to growth inhibitory effects of lovastatin therapy. The gene discussed is TP53; the disease is cancer.